周四盘中，微创脑科学（02172）股价出现大幅下跌，跌幅达7.25%，引发市场关注。该公司股价较月内高点15.24港元已累计下跌约25%，显示出近期明显的回调趋势。
微创脑科学近日发布了年度业绩报告，财务数据表现亮眼。公司2024年度收入达7.62亿元人民币，同比增长14.44%；权益股东应占溢利为2.54亿元，同比大幅增长74.63%。每股基本盈利为0.44元，公司拟派发末期股息每股0.11港元。业绩增长主要得益于海外业务的突破性进展，脑动脉粥样硬化狭窄产品市场份额提升，以及新产品的快速市场准入。
尽管公司业绩表现优异，但股价却出现大幅下跌，这种反常现象引起了投资者的疑虑。分析人士认为，这可能是由于前期股价涨幅较大，投资者选择获利了结。同时，市场可能对公司未来增长预期有所调整，导致部分投资者选择减持。此外，整体市场情绪波动也可能对个股表现产生影响。投资者需密切关注公司后续经营动态及市场反应。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.